Targeted cancer therapies

Targeted cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecules ("molecular targets") that are involved in the growth, progression, and spread of cancer. Targeted cancer therapies are sometimes called "molecularly targeted drugs," "molecularly targeted therapies," "precision medicines," or similar names. Targeted therapies are currently the focus of much anticancer drug development. They are a cornerstone of precision medicine, a form of medicine that uses information about a person’s genes and proteins to prevent, diagnose, and treat disease. Many targeted cancer therapies have been approved by the Food and Drug Administration (FDA) to treat specific types of cancer.

 

 

  • Hormone therapies
  • Signal transduction inhibitors
  • Gene expression modulators
  • Apoptosis inducers
  • Angiogenesis inhibitors

Related Conference of Targeted cancer therapies

April 22-23, 2019

Global Summit on Radiation Therapy & Targeted Tumors

Vancouver, Canada
June 12-13, 2019

22nd Canada Meetings on Radiology & Novel Cancer Therapies

Montreal, Quebec, Canada

Targeted cancer therapies Conference Speakers

Recommended Sessions

Related Journals

Are you interested in